Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nitrilase Mutant. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114277020B reveals a novel nitrilase mutant for phenylacetic acid synthesis. This report analyzes cost reduction in pharmaceutical intermediate manufacturing and supply chain reliability.
Patent CN115786313A reveals a novel nitrilase mutant boosting 2-chloronicotinic acid yield by 23.2 times, offering a green alternative for pharma and agrochemical intermediates.
Novel nitrilase mutant enhances acetophenone acid production efficiency. Sustainable biocatalysis solution for reliable pharmaceutical intermediate supply chain optimization.
Patent CN105505904A reveals enhanced nitrilase mutant for high-purity (R)-mandelic acid production with improved selectivity and activity for reliable supply.